Aaron Goff

Multi-Omics Technologies Applied to Tuberculosis Drug Discovery

S. Waddell, A. Goff, Dairre Cantillon, 2020, Applied Sciences.

Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach

S. Waddell, K. Fidler, D. Cantillon, 2022, The Lancet. Microbe.

Azetidines kill Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly

S. Waddell, L. Alderwick, J. Fossey, 2020, bioRxiv.

Dissecting the Mycobacterium bovis BCG Response to Macrophage Infection to Help Prioritize Targets for Anti-Tuberculosis Drug and Vaccine Discovery

P. Bettencourt, S. Waddell, D. Cantillon, 2022, Vaccines.